Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4746121> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- Q4746121 subject Q5920511.
- Q4746121 subject Q8298476.
- Q4746121 subject Q8844626.
- Q4746121 subject Q8919936.
- Q4746121 subject Q8965786.
- Q4746121 abstract "Amibegron (SR-58,611A) was a drug developed by Sanofi–Aventis (now Sanofi) which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.On July 31, 2008, Sanofi-Aventis announced that it has decided to discontinue development of amibegron.".
- Q4746121 atcPrefix "none".
- Q4746121 casNumber "121524-09-2".
- Q4746121 fdaUniiCode "PDQ3ME68U3".
- Q4746121 iupacName "Ethyl ([(7S)-7-([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy)acetate".
- Q4746121 pubchem "3035442".
- Q4746121 thumbnail Amibegron.svg?width=300.
- Q4746121 wikiPageWikiLink Q158205.
- Q4746121 wikiPageWikiLink Q17815528.
- Q4746121 wikiPageWikiLink Q389934.
- Q4746121 wikiPageWikiLink Q47273.
- Q4746121 wikiPageWikiLink Q5920511.
- Q4746121 wikiPageWikiLink Q62903.
- Q4746121 wikiPageWikiLink Q76560.
- Q4746121 wikiPageWikiLink Q8298476.
- Q4746121 wikiPageWikiLink Q8844626.
- Q4746121 wikiPageWikiLink Q8919936.
- Q4746121 wikiPageWikiLink Q8965786.
- Q4746121 atcPrefix "none".
- Q4746121 casNumber "121524".
- Q4746121 iupacName "Ethyl acetate".
- Q4746121 pubchem "3035442".
- Q4746121 unii "PDQ3ME68U3".
- Q4746121 type ChemicalSubstance.
- Q4746121 type Drug.
- Q4746121 type ChemicalObject.
- Q4746121 type Thing.
- Q4746121 type Q8386.
- Q4746121 comment "Amibegron (SR-58,611A) was a drug developed by Sanofi–Aventis (now Sanofi) which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.On July 31, 2008, Sanofi-Aventis announced that it has decided to discontinue development of amibegron.".
- Q4746121 label "Amibegron".
- Q4746121 depiction Amibegron.svg.